INS and Hepatic steatosis: Arruda et al. (2014) found that the expression of PACS-2 was up-regulated in the liver of ob/ob mice and HFD-induced obese mice, and silencing Pacs-2 improved insulin sensitivity and liver steatosis by decreasing MAM integrity and improving glucose metabolism, rather than regulating genes involved in de novo lipogenesis or cholesterol metabolism.